Gene signature-based prediction of tumor response to cyclophosphamide

Cancer Genomics and Proteomics

Volumn 4, Issue 3, 2007, Pages 187-196

  Korrat, André ^a   Greiner, Thomas ^a   Maurer, Martina ^a   Metz, Thomas ^a   Fiebig, Heinz Herbert ^a  

^a CHARLES RIVER LABORATORIES   (United States)

Author keywords

Gene expression profile; Independent validation; Leave one out cross validation; Microarray; Support vector machine; SVM; Tumor sensitivity

Indexed keywords

BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; GENE PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; LUNG SMALL CELL CANCER; MALE; MELANOMA; MONOTHERAPY; MOUSE; NONHUMAN; NUDE MOUSE; PREDICTION; TREATMENT RESPONSE; TUMOR CLASSIFICATION; TUMOR XENOGRAFT; VALIDATION STUDY;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; CYCLOPHOSPHAMIDE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249316540     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Armitage JO and Antman KH (eds.). High-dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells. Ed. 2. Baltimore: Williams & Wilkins 802, 1995.
2. DeVita VT, Serpick AA and Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73: 881, 1970.
3. Alexanian R, Salomon S and Bonnet J: Combination therapy for multiple myeloma. Cancer 40: 2765, 1977.
4. Skarin AT, Rosenthal DS, Moloney WC and Frei E: Combination chemotherapy of advanced non-Hodgkin's lymphoma with bleomycin, Adriamycin, cyclophosphamide, vinristine, and prednisone (BACOP). Blood 29: 759, 1977.
5. Muggia FM, Chia G, Reed LJ and Romney SL: Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinoma. J Obstet Gynecol 128: 314, 1977.
6. Livingston RB, Moore TW and Heilbrum L: Small cell carcinoma of the lung: combined chemotherapy and radiation. Ann Intern Med 88: 194, 1978.
7. Eder JP, Antman K, Peters W et al: High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. J Clin Oncol 4: 1592, 1986.
8. Fiebig HH, Dengler WA and Roth T: Human tumor xenografts: predictivity, characterization and discovery of new anticancer agents. In: Relevance of tumor models for anticancer drug development. Fiebig H-H, Burger AM (eds.). Contr Oncol Basel Karger 54: 29-50, 1999.
9. URL: http://www.affymetrix.com/support/technical/datasheets/ human_datasheet.pdf
10. Shi et al: The MicroArray Quality Control (MAQC) project shows interplatform reproducibility of gene expression measurements. Nature Biotechnology 24(9): 1151-1161, 2006.
11. Zhijin Wu and Rafael A: Irizarry, Robert Gentleman, Francisco Martinez Murillo, and Forrest Spencer. A Model Based Background Adjustment for Oligonucleotide Expression Arrays" (May 2004). Johns Hopkins University, Department of Biostatistics Working Papers. Working Paper 1.
12. Zhao Y, Pinilla C, Valmori D, Martin R and Simon R: Application of support vector machines for T-cell epitopes prediction. Bioinformatics 19: 1978-1984, 2003.
13. Peng S, Xu Q, Ling XB et al: Molecular classification of cancer types from microarray data using the combination of genetic algorithms and support vector machines. FEBS Lett 555: 358-362, 2003.
14. Furey TS, Cristianini N, Duffy N et al: Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16: 906-914, 2000.